Evidence map›Paper›PMID 36144577›Full record

ArticleMolecules (Basel, Switzerland)2022

A Carabrane-Type Sesquiterpenolide Carabrone from

Yi-Dan Zheng, Ying Zhang, Jun-Yi Ma, Chun-Yan Sang, Jun-Li Yang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Proteomics in pancreatic cancer.Biomarker research · 2025
    Review
  3. New Terpenoids and Polyphenolic Profile ofMolecules (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Review
  6. Nardoguaianone L Isolated fromMolecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yi-Dan ZhengCollege of Life Science, Northwest Normal University, Lanzhou 730070, China.
Ying ZhangCAS Key Laboratory of Chemistry of Northwestern Plant Resources and Key Laboratory for Natural Medicine of Gansu Province, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou 730000, China.
Jun-Yi MaCollege of Life Science, Northwest Normal University, Lanzhou 730070, China.
Chun-Yan SangCAS Key Laboratory of Chemistry of Northwestern Plant Resources and Key Laboratory for Natural Medicine of Gansu Province, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou 730000, China.
Jun-Li YangCAS Key Laboratory of Chemistry of Northwestern Plant Resources and Key Laboratory for Natural Medicine of Gansu Province, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou 730000, China.
Lanzhou Institute of Chemical Physics · CNNorthwest Normal University · CNChinese Academy of Sciences · CN

Funding

National Natural Science Foundation of China No. 32161143019Natural Science Foundation of Gansu Province 21JR7RA075Outstanding Youth Fund of Gansu Province 20JR10RA061the foundation of Chinese Academy of Sciences via Special Research Assistant Program E20458YZ
6 · The paper itself

Abstract

Pancreatic cancer has an extremely poor prognosis, and the clinical drugs for the treatment of pancreatic cancer are usually multi-drug combinations. Therefore, it is necessary to search for and find specific new bioactive agents against pancreatic cancer. Carabrone is a carabrane-type sesquiterpenolide extracted from

Indexed as

AsteraceaeFerroptosisPancreatic NeoplasmsCell Line, TumorCell ProliferationHumansPancreasCarpesium cernuum L.ferroptosisnatural productproteomicsSW1990 cells

Identifiers

PMID36144577
PMCPMC9503519
OpenAlexW4295213430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.